Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
18,320,102
-
Share change
-
-444,779
-
Total reported value
-
$154,069,337
-
Put/Call ratio
-
151%
-
Price per share
-
$8.41
-
Number of holders
-
89
-
Value change
-
-$5,403,918
-
Number of buys
-
30
-
Number of sells
-
43
Institutional Holders of BELLICUM PHARMACEUTICALS INC - COM (BLCM) as of Q4 2017
As of 31 Dec 2017,
BELLICUM PHARMACEUTICALS INC - COM (BLCM) was held by
89 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,320,102 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, FMR LLC, JPMORGAN CHASE & CO, BlackRock Inc., Vanguard Group Inc, STATE STREET CORP, NORTHERN TRUST CORP, Prosight Management, LP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and MORGAN STANLEY.
This page lists
89
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.